Manhattan Associates (MANH) Cash & Equivalents (2010 - 2026)

Manhattan Associates (MANH) has 17 years of Cash & Equivalents data on file, last reported at $226.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 9.84% year-over-year to $226.1 million; the trailing twelve-month figure through Mar 2026 stood at $226.1 million (up 9.84% YoY), and the FY2025 full-year result was $328.7 million, up 23.48% from the prior year.
• Cash & Equivalents eased to $226.1 million in Q1 2026, from $328.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $328.7 million in Q4 2025 to a low of $14.0 million in Q1 2022.
• A 5-year average of $180.3 million and a median of $205.9 million in 2025 frame the typical range for Cash & Equivalents.
• Peak annual rise in Cash & Equivalents reached 1359.67% in 2022, while the deepest fall reached 92.9% in 2022.
• Tracing MANH's Cash & Equivalents over 5 years: stood at $225.5 million in 2022, then grew by 20.08% to $270.7 million in 2023, then fell by 1.67% to $266.2 million in 2024, then climbed by 23.48% to $328.7 million in 2025, then tumbled by 31.21% to $226.1 million in 2026.
• Business Quant data shows MANH's Cash & Equivalents at $226.1 million in Q1 2026, $328.7 million in Q4 2025, and $263.6 million in Q3 2025.